SCHEMBL184382

SCHEMBL184382

O=C(Nc1nc(C(O)CO)ns1)C(OC1CCOCC1)c1ccc(S(=O)(=O)C2CC2)cc1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL625644 0.93 GCK (0.59) GCK
SCHEMBL19921745 0.87 GCK (0.63) GCK
SCHEMBL185328 0.84 GCK (0.74) GCK
SCHEMBL185441 0.83 GCK (0.72) GCK
SCHEMBL185094 0.83 GCK (0.69) GCK
SCHEMBL184643 0.82 GCK (1.00) GCK
SCHEMBL185835 0.79 GCK (0.84) GCK
SCHEMBL185624 0.78 GCK (0.66) GCK
SCHEMBL197031 0.78 GCK (0.68) GCK
SCHEMBL626565 0.78 GCK (0.44) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2402327-B1 Acetamide compounds as glucokinase activators, their process and medicinal applications IMPETIS BIOSCIENCES LTD (IN) 2018-03-07 EP claimed
EP-2402327-A1 Acetamide compounds as glucokinase activators, their process and medicinal applications Advinus Therapeutics Private Limited (IN) 2012-01-04 EP claimed
EP-2402327-B1 Acetamide compounds as glucokinase activators, their process and medicinal applications IMPETIS BIOSCIENCES LTD (IN) 2018-03-07 EP disclosed
EP-2402327-A1 Acetamide compounds as glucokinase activators, their process and medicinal applications Advinus Therapeutics Private Limited (IN) 2012-01-04 EP disclosed